{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3606, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/9", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "825692bf-ef60-4d3a-abde-2f257df821c0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The key takeaways, traction, and peer benchmark slides present the company's financial performance and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "Includes a legend for extraordinary items and a disclaimer regarding non-GAAP adjustments for FY 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/10", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-10", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3ef3fa20-bb22-44b9-89a5-9337ce403588", "evidence": "The traction and peer benchmark slides imply that investing in Pathward Financial can provide strong returns.", "position": 0, "objective": "Highlight the benefits of investing in Pathward Financial", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "825692bf-ef60-4d3a-abde-2f257df821c0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The key takeaways, traction, and peer benchmark slides present the company's financial performance and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Peer group defined as commercial insured banks with assets between $3-10 billion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/11", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-11", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3ef3fa20-bb22-44b9-89a5-9337ce403588", "evidence": "The traction and peer benchmark slides imply that investing in Pathward Financial can provide strong returns.", "position": 0, "objective": "Highlight the benefits of investing in Pathward Financial", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "825692bf-ef60-4d3a-abde-2f257df821c0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The key takeaways, traction, and peer benchmark slides present the company's financial performance and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a Venn-like circular layout to present two key capital return metrics alongside qualitative operational targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/12", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-12", "loopMatches": [ { "to": 12, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "3ef3fa20-bb22-44b9-89a5-9337ce403588", "evidence": "The traction and peer benchmark slides imply that investing in Pathward Financial can provide strong returns.", "position": 0, "objective": "Highlight the benefits of investing in Pathward Financial", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "825692bf-ef60-4d3a-abde-2f257df821c0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The key takeaways, traction, and peer benchmark slides present the company's financial performance and growth.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a grid of 8 metric cards, each with an icon, a headline number, and a descriptive sub-text.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/13", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "context", "function": "establish_context", "notes": "The diagram uses a hub-and-spoke model to visualize the central position of Pathward in the financial ecosystem.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/14", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "present_framework", "notes": "The slide uses a four-column layout to categorize business lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/15", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The chart highlights the acquisition of Crestmark in 2018.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/16", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "present_framework", "notes": "The slide uses a horizontal arrow to imply a unified, integrated approach across these four domains.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/17", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/18", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard financial disclosure slide for non-GAAP metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/19", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "business_model", "function": "present_framework", "notes": "The slide uses a hierarchical tree structure to represent the balance sheet components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/20", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "other", "function": "present_framework", "notes": "The slide uses two distinct waterfall diagrams to explain how Pathward secures its position in different financial products.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/21", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/22", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dc7b-736c-b904-981e7359f581", "docSlug": "8a10c1d3b74b5478e8a529020efac05e", "documentTitle": "Pathward Financial | Investor Presentation Deck | 23 slides", "authorId": "pathward-financial", "authorName": "Pathward", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix", "function": "appendix", "notes": "Two-column reference glossary with bolded term headings and short paragraph definitions; no charts or imagery beyond the page footer and Pathward logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dc7b-736c-b904-981e7359f581/23", "deckHref": "/decks/019de075-dc7b-736c-b904-981e7359f581", "deckAnchorHref": "/decks/019de075-dc7b-736c-b904-981e7359f581#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/WwaHMByhLYOdGsqVSy1Sq6y9unOhUWfsfyqAhmHdLjs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hOWNjMGM1MDhkNDVkODk4NWY1NzQwOGFjZTQ5Yjk2OS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/1", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/ed7LxKZZTq-3pNL-_p7gU7H7aIoGUPwAbc2OL8R2D9c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hOWNjMGM1MDhkNDVkODk4NWY1NzQwOGFjZTQ5Yjk2OS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/BzbgEpyOXjwWo0XiDK4lYsYzrgyqBV1ajyDOUcUTbEM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hOWNjMGM1MDhkNDVkODk4NWY1NzQwOGFjZTQ5Yjk2OS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/tSfsnk5d1DIAT4ZzwFrDlFDOZnMnLMMemp7SMlJgh4E/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hOWNjMGM1MDhkNDVkODk4NWY1NzQwOGFjZTQ5Yjk2OS9wMDAxLnBuZw" }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/2", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "use_of_funds", "function": "plan_implementation", "notes": "This is a standard IPO/follow-on offering summary table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/3", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a structured table format to present key company metrics and status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/4", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/5", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization for drug development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/6", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "comparison_table", "function": "compare_peers", "notes": "Uses a visual metaphor of 'Outside in' vs 'Precise from within' to contrast the two treatment modalities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/7", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a simple comparison framework to highlight clinical benefits.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/8", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a comparison framework to justify the use of alpha-emitting isotopes in targeted radiotherapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/9", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "c50d4ad9-887f-4c32-8d82-c72b06c2e782", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem statement, highlighting the limitations of current cancer treatments and the unmet need in NETs.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "why_now", "function": "argue_timing", "notes": "The slide uses a chronological progression of therapeutic classes (Targeted, Immuno-oncology, ADCs, Cell Therapy) leading to RPT.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/10", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "993d8b01-aa58-414e-8912-0e3cffca5321", "evidence": "The document presents the current market trends and growth opportunity in radiopharmaceuticals.", "position": 1, "objective": "Why is now the right time for RPTs in cancer treatment?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "c50d4ad9-887f-4c32-8d82-c72b06c2e782", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem statement, highlighting the limitations of current cancer treatments and the unmet need in NETs.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/11", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "993d8b01-aa58-414e-8912-0e3cffca5321", "evidence": "The document presents the current market trends and growth opportunity in radiopharmaceuticals.", "position": 1, "objective": "Why is now the right time for RPTs in cancer treatment?", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "c50d4ad9-887f-4c32-8d82-c72b06c2e782", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem statement, highlighting the limitations of current cancer treatments and the unmet need in NETs.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a process flow diagram to show the standard of care progression for two types of NETs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/12", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-12", "loopMatches": [ { "to": 14, "from": 12, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53cf3362-2492-4fd7-a1a1-affed636c3a5", "evidence": "The document highlights the unmet need in NETs and the potential market opportunity.", "position": 0, "objective": "What is the cost of inaction in addressing the unmet need in NETs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 9, "beatId": "c50d4ad9-887f-4c32-8d82-c72b06c2e782", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem statement, highlighting the limitations of current cancer treatments and the unmet need in NETs.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a Kaplan-Meier curve to contrast Lutathera against a control group, highlighting the clinical limitation of the current standard of care.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/13", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-13", "loopMatches": [ { "to": 14, "from": 12, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53cf3362-2492-4fd7-a1a1-affed636c3a5", "evidence": "The document highlights the unmet need in NETs and the potential market opportunity.", "position": 0, "objective": "What is the cost of inaction in addressing the unmet need in NETs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "why_now", "function": "size_opportunity", "notes": "The chart compares median progression vs median survival in months across three patient cohorts (Pancreatic, GI, Overall).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/14", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-14", "loopMatches": [ { "to": 14, "from": 12, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53cf3362-2492-4fd7-a1a1-affed636c3a5", "evidence": "The document highlights the unmet need in NETs and the potential market opportunity.", "position": 0, "objective": "What is the cost of inaction in addressing the unmet need in NETs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a chemical structure comparison to illustrate the similarity in binder/chelator while highlighting the difference in radioisotope.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/15", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process-oriented layout to show the transition between trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/16", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-16", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table specifically highlights that there were zero treatment-related serious adverse events (SAE) and zero discontinuations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/17", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-17", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/18", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-18", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable Disease).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/19", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-19", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 20, "slideType": "comparison_table", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/20", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-20", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "a134e4cc-5c5e-4ea7-8bd8-6d4ed3346f90", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents RYZ101 as a solution to the unmet need in NETs, highlighting its promising characteristics and clinical trial results.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 21, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide uses a standard clinical trial flow diagram (Population -> Treatment -> Endpoints -> Crossover).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/21", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-21", "loopMatches": [ { "to": 21, "from": 16, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "dd065b7b-77b8-4f37-837e-80ec7e755de5", "evidence": "The document presents clinical trial results for RYZ101, including Phase 1b preliminary response analysis and efficacy data.", "position": 2, "objective": "How does RYZ101 perform in clinical trials?", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.7, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 22, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a three-column layout to break down the market opportunity into patient population, pricing, and launch dynamics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/22", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 22, "beatId": "4eb5bdc2-46df-4e7d-90bc-1dad24a39c2b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides market sizing information for RYZ101 in GEP-NETS.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 23, "slideType": "other", "function": "analyze_data", "notes": "The slide highlights that 47% of SCLC samples show some level of SSTR2 expression, with 27% showing high expression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/23", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "Includes a visual case study with PET scan images showing tumor reduction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/24", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "The chart shows tumor growth over 57 days across four treatment groups, with the combination therapy (green line) demonstrating the most effective tumor suppression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/25", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 26, "slideType": "other", "function": "plan_implementation", "notes": "The slide outlines a clinical trial protocol for a combination therapy involving RYZ101, chemotherapy, and PD-L1 inhibitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/26", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "Includes PET scan imagery and a pharmacokinetic tumor uptake graph comparing RAYZ-SSTR to DOTATATE.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/27", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 28, "slideType": "other", "function": "present_solution", "notes": "CMC stands for Chemistry, Manufacturing, and Controls. The slide highlights infrastructure investment and current CDMO reliance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/28", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 29, "slideType": "solution", "function": "present_solution", "notes": "The workflow includes a feedback loop from in vivo screening back to binder discovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/29", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 30, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a staircase-style diagram to represent progression in clinical relevance of data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/30", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 31, "slideType": "solution", "function": "present_solution", "notes": "Includes IHC staining images and a waterfall plot showing tumor shrinkage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/31", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "The slide demonstrates the efficacy and specificity of the drug candidate in a preclinical model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/32", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 33, "slideType": "traction", "function": "show_traction", "notes": "Comparison of 225Ac vs 177Lu efficacy at significantly different dose levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/33", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 34, "slideType": "traction", "function": "show_traction", "notes": "Includes clinical imaging examples for two patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/34", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 35, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a longitudinal imaging sequence to demonstrate drug efficacy/retention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/35", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 36, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process flow diagram to illustrate the regulatory and clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/36", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 37, "slideType": "traction", "function": "show_traction", "notes": "The slide lists 24 investor logos/names.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/37", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 38, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/38", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 39, "slideType": "team_bio", "function": "other", "notes": "Includes 88 FTEs count and board member list.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/39", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 39, "from": 39, "beatId": "b1b90c07-22d7-4572-9e13-314d9970d9bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The document presents information about RayzeBio's experienced and entrepreneurial life sciences team.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 40, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a vertical process flow to illustrate vertical integration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/40", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-dd1e-7468-9323-d12fde1b7732", "docSlug": "a9cc0c508d45d8985f57408ace49b969", "documentTitle": "RayzeBio | IPO Presentation Deck | 41 slides", "authorId": "rayzebio", "authorName": "RayzeBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 41, "slideType": "mission", "function": "inspire_vision", "notes": "This is a closing or transition slide featuring the company logo and mission statement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-dd1e-7468-9323-d12fde1b7732/41", "deckHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732", "deckAnchorHref": "/decks/019de075-dd1e-7468-9323-d12fde1b7732#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-de11-77d2-b45d-bba0e62d0581", "docSlug": "774976cd9163856c4e74363023c5160c", "documentTitle": "Rent The Runway | Results Presentation Deck | 32 slides", "authorId": "rent-the-runway", "authorName": "Rent The Runway", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/iKQM_IxFiE6aOR-wds5ornI3JMOhQxrcGt8jr_Wbkmk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NzQ5NzZjZDkxNjM4NTZjNGU3NDM2MzAyM2M1MTYwYy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-de11-77d2-b45d-bba0e62d0581/1", "deckHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581", "deckAnchorHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/dQhV1tfazWBHchv_0RLe6IjFG5m1wNk1PJoqyAOlyuY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NzQ5NzZjZDkxNjM4NTZjNGU3NDM2MzAyM2M1MTYwYy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/1KxTa-A-7CNRLtI6Sb5mW2YjAL_KlN1mdnV91Y50FIs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NzQ5NzZjZDkxNjM4NTZjNGU3NDM2MzAyM2M1MTYwYy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Zh5k4VwuTOdTGIVP2oSq9HId1k6UUWZxmmbEx5e7kWA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NzQ5NzZjZDkxNjM4NTZjNGU3NDM2MzAyM2M1MTYwYy9wMDAxLnBuZw" }, { "docId": "019de075-de11-77d2-b45d-bba0e62d0581", "docSlug": "774976cd9163856c4e74363023c5160c", "documentTitle": "Rent The Runway | Results Presentation Deck | 32 slides", "authorId": "rent-the-runway", "authorName": "Rent The Runway", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-de11-77d2-b45d-bba0e62d0581/2", "deckHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581", "deckAnchorHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-de11-77d2-b45d-bba0e62d0581", "docSlug": "774976cd9163856c4e74363023c5160c", "documentTitle": "Rent The Runway | Results Presentation Deck | 32 slides", "authorId": "rent-the-runway", "authorName": "Rent The Runway", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a 2x2 grid layout to present four key financial metrics over a four-year period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-de11-77d2-b45d-bba0e62d0581/3", "deckHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581", "deckAnchorHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-de11-77d2-b45d-bba0e62d0581", "docSlug": "774976cd9163856c4e74363023c5160c", "documentTitle": "Rent The Runway | Results Presentation Deck | 32 slides", "authorId": "rent-the-runway", "authorName": "Rent The Runway", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-de11-77d2-b45d-bba0e62d0581/4", "deckHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581", "deckAnchorHref": "/decks/019de075-de11-77d2-b45d-bba0e62d0581#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }